Amyris Biorefinery Successfully Restarts Industrial Production in Brazil
April 16 2014 - 8:00AM
Amyris, Inc. (Nasdaq:AMRS), the leading synthetic biology innovator
and renewable products company, today announced its industrial
fermentation plant, located in the town of Brotas in southeastern
Brazil, has successfully resumed industrial production following a
planned maintenance period.
"As expected, our Brotas biorefinery has started up well
following our planned upgrades and, thanks to our experienced team,
is delivering similar operational performance to what we
experienced in our quality runs in late 2013. We remain on track
with our 2014 business plan and look forward to producing our first
fragrance oil, patchouli, later this year at Brotas," said John
Melo, Amyris President & CEO.
As announced in December 2013, the Company took advantage of the
inter-harvest sugarcane season to make improvements to the Brotas
plant to prepare for 2014 production of patchouli in addition to
Biofene®, Amyris's brand of renewable farnesene. The plant
improvements were completed on time and under budget prior to the
start of the sugarcane harvest season. The Brotas plant has resumed
production of farnesene and is operating as planned.
"In 2013, we successfully scaled our Brotas plant with record
volumes of farnesene produced, started contract manufacturing
initial volumes of our first fragrance molecule, and significantly
expanded our customer and product portfolio. In 2014, as I wrote in
my letter to our stockholders in our Annual Report, we expect to
build on this success as we plan deliver not just one — but two —
high-value renewable molecules from our Brotas plant, demonstrating
the benefits to our partners of industrializing synthetic biology.
We are pleased with the successful scale-up of three fermentation
molecules and the successful restart of our plant, as well as
recently announced additions to and expansions of our collaboration
portfolio," added Melo.
About Amyris
Amyris is an integrated renewable products company focused on
providing sustainable alternatives to a broad range of
petroleum-sourced products. Amyris uses its industrial synthetic
biology platform to convert plant sugars into a variety of
molecules -- flexible building blocks that can be used in a wide
range of products. Amyris is commercializing these products both as
No Compromise® renewable ingredients in cosmetics, flavors and
fragrances, polymers, lubricants and consumer products, and also as
No Compromise renewable diesel and jet fuel. Amyris Brasil Ltda., a
subsidiary of Amyris, oversees the establishment and expansion of
Amyris' production in Brazil. More information about Amyris is
available at www.amyris.com.
Forward-Looking Statements
This release contains forward-looking statements, and any
statements other than statements of historical facts could be
deemed to be forward-looking statements. These forward-looking
statements include, among other things, statements regarding future
events (such as Amyris's plans to manufacture patchouli at its
Brotas manufacturing plant) that involve risks and uncertainties.
These statements are based on management's current expectations and
actual results and future events may differ materially due to risks
and uncertainties, including those associated with potential
complications in the launch of a new product sales initiative,
uncertainty regarding demand levels for Biofene, Amyris' reliance
on third parties to achieve its goals, and other risks detailed in
the "Risk Factors" section of Amyris' quarterly report on Form 10-K
filed on April 2, 2014. Amyris disclaims any obligation to update
information contained in these forward-looking statements whether
as a result of new information, future events, or otherwise.
Amyris, the Amyris logo, Biofene and No Compromise are
trademarks or registered trademarks of Amyris, Inc.
CONTACT: Amyris, Inc.
Media & Investor Relations
Joel Velasco
info@amyris.com
Amyris (NASDAQ:AMRS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amyris (NASDAQ:AMRS)
Historical Stock Chart
From Apr 2023 to Apr 2024